Research / ACA / Fundamental state Inspectable configuration
State dimensions Filing 0001739445-23-000130 General Corporate
Debt relative to revenue 68th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.debt_to_revenue
90.71% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.98% · OPTIONAL · VALID
Operating cash generation 94th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
21.82% · OPTIONAL · VALID
Revenue growth 7th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
-2.99% · CORE · VALID
Inventory pressure 47th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
60.64% · OPTIONAL · VALID
Operating margin 53th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
8.72% · CORE · VALID
SBC intensity 100th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.21% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 28 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 97.41%
Current 90.71%
Delta -6.70% Capex Intensity Increased
Previous 8.08%
Current 8.98%
Delta 0.89% Cash Generation Increased
Previous 4.97%
Current 21.82%
Delta 16.85% Growth Decreased
Previous 2.50%
Current -2.99%
Delta -5.49% Inventory Pressure Increased
Previous 59.78%
Current 60.64%
Delta 0.86% Profitability Decreased
Previous 13.67%
Current 8.72%
Delta -4.95% Sbc Intensity Increased
Previous 1.00%
Current 1.21%
Delta 0.21% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.